Mold/Pollens Animals Colds Dust Exercise Smoke Weather Fragrance
Green Zone: Doing Well
● Breathing is good ● No cough wheeze ● Can work and play ● Sleeps all night
● No early warning signs ● Peak Flow Meter if used: 80-100% of personal best _________
School Action: Follow actions in marked boxes below for exercise induced asthma
Medication with spacer: Albuterol Ventolin Proventil Xopenex Medication without spacer: Maxair Autohaler Dose: __ puffs When: 10-15 minutes before listed activity Start Date: School Year ___ Stop Date: School Year ___
Yellow Zone: Getting Worse
● Cough, wheeze, chest tight ● Problems working/playing
● Early warning signs ● Shortness of breath
● Peak Flow Meter if used: 50 to 80% of personal best _________________
School Actions: Follow actions in marked boxes below Take Quick-Relief Medication How Much (Dose) Start Date Stop Date MDI with Spacer:
Albuterol Ventolin Proventil Xopenex
Without spacer: Maxair Autohaler Nebulizer:
Albuterol Ventolin Proventil Xopenex
If symptoms improve after 10-15 minutes: Return to normal activity If symptoms do not improve after 10-15 minutes: Give quick relief medication again and call parents If symptoms improve after the second 10-15 minutes: Return to normal activity and call parents If symptoms do not improve after the medication is repeated: Call EMS (911), School RN and parents If symptoms get worse at anytime: Call EMS (911), School RN and parents Report frequent use of quick relief medications (twice a day for 3 days, not for exercise) to the School RN and parents Red Zone:
● Cannot stop coughing ● Breathing fast ● Flaring nostrils ● Medication not helping
Medical Alert
● Getting worse, instead of better ● Trouble walking or talking from shortness of breath
● The skin between the ribs and above the collarbone pulls in or retracts
School Actions: 1. Call EMS (911) IMMEDIATELY 2. GIVE QUICK-RELIEVER MEDICATION AND CONTINUE EVERY 15 MINUTES UNTIL EMS (911) ARRIVES 3. Call School RN and Parents Take Quick-Relief Medication How Much (Dose) Start Date Stop Date MDI with Spacer:
Albuterol Ventolin Proventil Xopenex
Without spacer: Maxair Autohaler
Nebulizer:
Albuterol Ventolin Proventil Xopenex
Health Care Provider Name: Health Care Provider Sign: NEOLA 2005
Student Name: ____________________________________ Birth Date: ________________________ Address: _________________________________________ School Asthma Action Plan (page 2) Metered Dose Inhaler (MDI) Instructions
2. Shake the MDI for 5 seconds before each use.
3. Prime the MDI before the first use or when not used every day. Follow the product's
patient information sheet for MDI specific priming instructions. Priming usually involves pressing down on the medication canister to discard into the air one or more puff of medication. Discarding puffs makes sure the next puff inhaled contains the labeled amount of medication.
4. Keep track of metered inhalation puffs used. Subtract the number used from the number
of metered inhalation puffs available listed on the label. The number of metered inhaled puffs available is listed on the medication canister or on the box. There are usually 200 puffs in an MDI.
5. Ask family for a new MDI when all labeled metered inhalation puffs are used.
MDI and Aerosol Solution Potential Adverse Reaction: Headache, shakiness, fast heart rate, nausea. Call parent with 1) student report of symptoms that interfere with schoolwork or activity 2) increase in side effects 3) frequent usage (2 times a day for 3 days). We have instructed the patient and family in the proper use of the quick-relief medications. It is my professional opinion that the student: _____ should be allowed to carry and self administer the inhaled medication. _____ should not carry and self administer the inhaled medication. The medication should be stored and administered by designated school personnel. ___________________________________________
********************************************************************************************************************* Section II To Be Completed by Parent I give permission for my child to receive medication at school in keeping with Section I above according to the School District policy and as instructed by the physician and agree to 1) Assume responsibility for safe delivery of the medication in its original container to the school, 2) Have a new form completed by the doctor if medication or dosage is changed, 3) Notify the school of changes in health care provider. I release from liability, and in addition agree to indemnify, all school employees, the Board of Education and Akron Children's Hospital School Health Services for damages or injury resulting from the use, misuse or nonuse of such medication except as such Board, School Health Service or its employees are grossly negligent or engage in wanton or reckless misconduct. I further agree to submit a revised statement signed by the Physician who has prescribed the medication described in Section I in the event that I become aware that any of the above information has changed. I have read and understand the policy of the School Board for administration of medication and affirm that this request entails special circumstances justifying an exception from the usual administration of medication at school-by-school personnel. Parent/Guardian Signature: ________________________________________ Date: ______________ Daytime Phone: _________________________________________ THIS FORM EXPIRES AT THE END OF THE SCHOOL YEAR 9/1/01 10/1/13
Early Communication of an Ongoing Safety Review: BisphosphonatesFDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER Early Communication of an Ongoing Safety Review Bisphosphonates: Alendronate (Fosamax, Fosamax Plus D), Etidronate (Didronel), Ibandronate (Boniva), Pamidronate (Aredia), Risedronate (Actonel, Actonel W/Calcium), Ti
Resistencia antimicrobiana y epidemiología entérica serovar Enteritidis aisladas en las provincias de Chaco y Corrientes (Argentina) biotipos, fagos y colicinas, pruebas de susceptibilidad antimicrobiana, perfil plasmídico, análisis del ADN cromosómico total por electroforesis en campo pulsátil (PFGE), estudio de secuencias IS200, análisis mediante PCR de las secuencias REP (repetitive